Whitepaper
The Enterprise Data Catalog: Build or Buy
Every business is trying to become data driven, and managing data as a true economic asset is a fundamental part of that transformation. The enterprise data catalog has emerged as a key technology enabler for creating a ‘single source of reference,’ helping organizations overcome the complexities presented by the sheer amount of data, tools, and users.
But once you have decided that an enterprise data catalog is right for your organization, then you need to decide whether to build one internally or buy one. In this white paper, get a sense of the key considerations before deciding whether to “build or buy.” And, learn lessons from data catalog journeys of some of the most tech-savvy companies in the industry.
Download this white paper to learn:
The need for and the essential components of a robust data catalog
Important factors to consider when deciding whether to build or buy
Insights into the data catalog journeys of several Fortune 500s
Access your complimentary copy of ‘The Enterprise Data Catalog: Build or Buy?’ white paper now.
Related resources
Webinar Registration
Mastering Critical Data Elements: Governance Strategies Best Practices
In this webinar, discover how to unlock the full potential of your Critical Data Elements (CDEs) by focusing on where to start, how to govern them effectively, and the value they bring when managed well. We’ll explore how Alation’s powerful features can help you define, govern, and maintain trust in CDEs to drive business outcomes while meeting regulatory demands like APRA CPS 230. Learn actionable steps to establish strong CDE governance, empowering data users to make informed decisions with trusted, compliant data.
Register
Alation Brief
How to Assess Your Organization's Data Maturity
Is your organization data mature? Can people access and leverage the data they need to drive meaningful business results? Addressing this question is no easy task. Luckily, Alation has transformed thousands of hours guiding customers along this journey into an assessment you can use, too.
Watch now
Webinar Registration
Life Sciences & Pharmaceuticals: Data Trust for AI
Gen AI capabilities are being explored across different functional areas, from Research & Development (Derisking Drug Discovery) to Clinical Trials (Accelerated time to market) to Commercials (reinventing HCP engagement). A McKinsey survey revealed that 79% of LS organizations plan to build their own gen AI solutions tailored to their unique requirements.
Register